Skip to main content

Articles

Page 7 of 33

  3. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Shinichiro Shirouzu, Naohiro Sugita, Narantsog Choijookhuu, Yu Yamaguma, Kanako Takeguchi, Takumi Ishizuka, Mio Tanaka, Fidya, Kengo Kai, Etsuo Chosa, Yoshihiro Yamashita, Chihiro Koshimoto and Yoshitaka Hishikawa
    Citation: Journal of Ovarian Research 2023 16:21
    Content type: Correction Published on:

    The original article was published in Journal of Ovarian Research 2022 15:133

  4. Borderline tumors are malignant epithelial ovarian tumors with a very low incidence. Thus experience in diagnostics and treatment is still rare. The aim of this study was to present and analyze data of women w...

    Authors: B. Kipp, A. Vidal, D. Lenick and C. Christmann-Schmid
    Citation: Journal of Ovarian Research 2023 16:20
    Content type: Research Published on:

  5. The intra-abdominal cavity, surrounded by adipocytes, is the main metastatic site of epithelial ovarian, fallopian tube, and peritoneal cancer. Epidemiological and molecular studies have demonstrated a link be...

    Authors: Sooji Ham, Jin Hwa Choi, Soo Gui Shin and Eun-Ju Lee
    Citation: Journal of Ovarian Research 2023 16:19
    Content type: Research Published on:

  6. 2020 World Health Organization Classification of Female Genital Tumors removed ovarian seromucinous carcinoma as a distinct entity and recategorized it as ovarian endometrioid carcinoma with mucinous different...

    Authors: Yi Hu, Kun Fu, Huining Liu, Qiongqiong He, Xiaoqin Qiu, Wenqing Yang and Yu Zhang
    Citation: Journal of Ovarian Research 2023 16:18
    Content type: Research Published on:

  7. Ovarian cancer (OC) is one of the commonest and deadliest diseases that threaten the health of women worldwide. It is essential to find out its pathogenic mechanisms and therapeutic targets for OC patients. Al...

    Authors: Meng Ren, Hongyu Zhao, Yan Gao, Qi Chen, Xiaoting Zhao and Wentao Yue
    Citation: Journal of Ovarian Research 2023 16:17
    Content type: Research Published on:

  8. Endometrial cancer (EC) is one of the most common gynecologic malignancies. Identification of potential EC biomarkers is essential to improve the prognosis and development of therapies against EC. Synaptotagmi...

    Authors: Cai Meijuan, Xu Meng, Liu Fang and Wang Qian
    Citation: Journal of Ovarian Research 2023 16:16
    Content type: Research Published on:

  9. Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, anovulation, and polycystic ovaries. Electroacupuncture (EA) can effectively improve hyperandrogenism and increase ovulation frequency in ...

    Authors: Ge Xu, Xuedan Zhao, Zhihao Li, Junwei Hu, Xu Li, Juanjuan Li and Yuelai Chen
    Citation: Journal of Ovarian Research 2023 16:15
    Content type: Research Published on:

  10. Resistance to chemotherapy continues to be a challenge when treating epithelial ovarian cancer (EOC), contributing to low patient survival rates. While CA125, the conventional EOC biomarker, has been useful in...

    Authors: Emma Gerber, Meshach Asare-Werehene, Arkadiy Reunov, Dylan Burger, Tien Le, Euridice Carmona, Anne-Marie Mes-Masson and Benjamin K. Tsang
    Citation: Journal of Ovarian Research 2023 16:14
    Content type: Research Published on:

  11. Ovarian absence is an uncommon condition that most frequently presents unilaterally. Several etiologies for the condition have been proposed, including torsion, vascular accident, and embryological defect. A s...

    Authors: H. Alexander Chen, Alyssa A. Grimshaw, Melissa Taylor-Giorlando, Pavithra Vijayakumar, Dan Li, Miranda Margetts, Emanuele Pelosi and Alla Vash-Margita
    Citation: Journal of Ovarian Research 2023 16:13
    Content type: Review Published on:

  12. Ovarian cancer is a highly heterogeneous gynecological malignancy that seriously affects the survival and prognosis of female patients. Single-cell sequencing and transcriptome analysis can effectively charact...

    Authors: Zitao Wang, Jie Zhang, Fangfang Dai, Bingshu Li and Yanxiang Cheng
    Citation: Journal of Ovarian Research 2023 16:12
    Content type: Research Published on:

  13. Cell-free DNA (cfDNA) is emerging as a potential biomarker for the detection of ovarian cancer (OC). Recently, we reported a method based upon cfDNA whole-genome sequencing data including the nucleosome distri...

    Authors: Huimei Zhou, Xueying Zhang, Qian Liu, Jiaxin Yang, Jian Bai, Min Yin, Dongyan Cao, Qingzheng Zhang and Lu Zheng
    Citation: Journal of Ovarian Research 2023 16:11
    Content type: Research Published on:

  14. Many epidemiological studies have shown that anovulatory polycystic ovary syndrome (PCOS) is accompanied by hyperandrogenism. However, the exact mechanism of hyperandrogen-induced anovulation remains to be elu...

    Authors: Xin Zeng, Qiaoqing Zhong, Ming Li, Yating Liu, Shuanglian long, Yuanjie Xie and Zhongcheng Mo
    Citation: Journal of Ovarian Research 2023 16:10
    Content type: Research Published on:

  15. Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by chronic ovulation dysfunction and overabundance of androgens; it affects 6–20% of women of reproductive age. PCOS involves vario...

    Authors: Han Zhao, Jiaqi Zhang, Xiangyi Cheng, Xiaozhao Nie and Bing He
    Citation: Journal of Ovarian Research 2023 16:9
    Content type: Review Published on:

  16. Chemotherapy is among the most common treatment methods for ovarian cancer (OC). However, chemoresistance limits the effectiveness of chemotherapy and leads to treatment failure. We herein investigate the biol...

    Authors: Shufen Wang, Yan Ma, Yi Hu, Xia Zhao, Yilin Li, Shuming Ouyang and Guifang Luo
    Citation: Journal of Ovarian Research 2023 16:8
    Content type: Research Published on:

  17. To determine the optimal endometrial preparation protocol for a frozen embryo transfer in patients with endometriosis.

    Authors: Yaxin Guo, Zishui Fang, Lin Yu, Xin Sun, Fei Li and Lei Jin
    Citation: Journal of Ovarian Research 2023 16:7
    Content type: Research Published on:

  18. As a kind of gynecological tumor, ovarian cancer is not as common as cervical cancer and breast cancer, but its malignant degree is higher. Despite the increasingly mature treatment of ovarian cancer, the five...

    Authors: Yongsong Wu, Shilin Xu, Shanshan Cheng, Jiani Yang and Yu Wang
    Citation: Journal of Ovarian Research 2023 16:6
    Content type: Review Published on:

  19. Ovarian cancer (OC) is the most fatal gynaecological malignancy and has a poor prognosis. Glycosylation, the biosynthetic process that depends on specific glycosyltransferases (GTs), has recently attracted inc...

    Authors: Xuyao Xu, Yue Wu, Genmei Jia, Qiaoying Zhu, Dake Li and Kaipeng Xie
    Citation: Journal of Ovarian Research 2023 16:5
    Content type: Research Published on:

  20. In an in vitro fertilization (IVF) cycle, the embryo ends its wandering time and begins the process of implantation into the uterine cavity on the seventh day after oocyte pick-up (OPU + 7), which is closer th...

    Authors: Wenxian Zhao, Honglu Diao, Xin Chen, Shaoyuan Xu, Shengfang Jiang, Hong Cao, Changjun Zhang and Ying Zhang
    Citation: Journal of Ovarian Research 2023 16:4
    Content type: Research Published on:

  21. B7-H4 is expressed in various types of cancers and its expression inversely correlates with the degree of tumor-infiltrating lymphocytes (TILs). Studies have shown the relationship between B7-H4, cancer stem c...

    Authors: Chungsu Hwang, Hyun Jung Lee, Ju-Young Na, Ki Hyung Kim, Yong Jung Song, Jee Yeon Kim, Kyungbin Kim, Dong Hoon Shin, Joon Young Park, So Young Kim, Jung Hee Lee and Kyung Un Choi
    Citation: Journal of Ovarian Research 2023 16:3
    Content type: Research Published on:

  22. Premature ovarian insufficiency (POI) patients are predisposed to metabolic disturbances, including in lipid metabolism and glucose metabolism, and metabolic disorders appear to be a prerequisite of the typica...

    Authors: Xing-Yu Zhou, Xin Li, Jun Zhang, Ying Li, Xiao-Min Wu, Yi-Zhen Yang, Xiao-Fei Zhang, Lin-Zi Ma, Yu-Dong Liu, Zhe Wang and Shi-Ling Chen
    Citation: Journal of Ovarian Research 2023 16:2
    Content type: Research Published on:

  23. We aimed to evaluate the prognostic value of C-C motif chemokine receptor type 5 (CCR5) expression level for patients with ovarian cancer and to establish a radiomics model that can predict CCR5 expression lev...

    Authors: Sheng Wan, Tianfan Zhou, Ronghua Che, Ying Li, Jing Peng, Yuelin Wu, Shengyi Gu, Jiejun Cheng and Xiaolin Hua
    Citation: Journal of Ovarian Research 2023 16:1
    Content type: Research Published on:

  24. Polycystic ovary syndrome (PCOS) is a gynaecological endocrine disease. The objective of the present study was to investigate the role of GTPase immunity-associated protein (GIMAP) 7 in PCOS. A PCOS rat model ...

    Authors: Anran Xu, Yuanyuan Fan, Song Liu, Lianbing Sheng, Yanyan Sun and Huijun Yang
    Citation: Journal of Ovarian Research 2022 15:141
    Content type: Research Published on:

  25. The aim of surgery for advanced-stage ovarian cancer is a complete cytoreduction, because this is the most important independent prognostic factor for prolonged survival. Yet this can be difficult to achieve w...

    Authors: Gatske M. Nieuwenhuyzen-de Boer, Nick J. van de Berg, Xu Shan Gao, Patricia C. Ewing-Graham and Heleen J. van Beekhuizen
    Citation: Journal of Ovarian Research 2022 15:140
    Content type: Research Published on:

  26. Ovarian insufficiency frequently renders postmenopausal women susceptible to osteoporosis and dyslipidaemia. Postmenopausal transplant women are at a higher risk developing osteoporosis and dyslipidaemia due t...

    Authors: Encheng Zhou, Du Xiang, Bin Yu, Hanlin Yao, Chao Sun and Yanfeng Wang
    Citation: Journal of Ovarian Research 2022 15:139
    Content type: Research Published on:

  27. Exposure to cyclophosphamide (CTX) induces premature ovarian insufficiency (POI). Quercetin is a natural flavonoid that exhibits anti-inflammatory and antioxidant properties, and its antioxidant activity is co...

    Authors: Yun Chen, Ying Zhao, Chenyun Miao, Liuqing Yang, Ruye Wang, Bixia Chen and Qin Zhang
    Citation: Journal of Ovarian Research 2022 15:138
    Content type: Research Published on:

  28. Cells are an essential part of the triple principles of tissue engineering and a crucial component of the engineered ovary as they can induce angiogenesis, synthesize extracellular matrix and influence follicl...

    Authors: Arezoo Dadashzadeh, Saeid Moghassemi, Monika Grubliauskaité, Hanne Vlieghe, Davide Brusa and Christiani A. Amorim
    Citation: Journal of Ovarian Research 2022 15:137
    Content type: Research Published on:

  29. Letrozole has been reported to be effective in treating anovulation, preventing ovarian hyperstimulation syndrome (OHSS), and retrieving oocytes in breast cancer patients. However, the role and mechanism of le...

    Authors: Fukiko Kasuga-Yamashita, Tsuyoshi Baba, Sachiko Nagao, Yuya Fujibe, Miyuki Morishita, Yoshika Kuno, Tasuku Mariya, Hiroyuki Honnma, Toshiaki Endo, Tamotsu Kiya and Tsuyoshi Saito
    Citation: Journal of Ovarian Research 2022 15:136
    Content type: Research Published on:

  31. Peritoneal dissemination is the predominant feature of malignant progression in ovarian cancer and is a major cause of poor surgical outcomes and clinical prognoses. Abnormal glycosylation of carbohydrate anti...

    Authors: Xiayu Jin, Ming Du, Yisheng Wang, Yuefei Wang, Yingying Lu, Congjian Xu and Xiaoyan Zhang
    Citation: Journal of Ovarian Research 2022 15:134
    Content type: Research Published on:

  32. High-Mobility Group Box 1 (HMGB1) and HMGB2 are chromatin-associated proteins that belong to the HMG protein family, and are involved in the regulation of DNA transcription during cell differentiation, prolife...

    Authors: Shinichiro Shirouzu, Naohiro Sugita, Narantsog Choijookhuu, Yu Yamaguma, Kanako Takeguchi, Takumi Ishizuka, Mio Tanaka, Fidya, Kengo Kai, Etsuo Chosa, Yoshihiro Yamashita, Chihiro Koshimoto and Yoshitaka Hishikawa
    Citation: Journal of Ovarian Research 2022 15:133
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:21

  33. Ovarian reserve reflects both the quantity and quality of oocytes available for procreation and is affected by many known and unknown factors. ABO blood type is related to several infertility processes, but it...

    Authors: Xingyu Sun, Chenyu Sun, Muzi Meng and Ling Liu
    Citation: Journal of Ovarian Research 2022 15:132
    Content type: Research Published on:

  34. Angiopoietin-like 4 (ANGPTL4) is highly expressed in a variety of neoplasms and promotes cancer progression. Nevertheless, the mechanism of ANGPTL4 in ovarian cancer (OC) metastasis remains unclear. This study...

    Authors: Yinping Liu, Rui Yang, Yan Zhang, Yaping Zhu and Wei Bao
    Citation: Journal of Ovarian Research 2022 15:131
    Content type: Research Published on:

  35. Ovarian clear cell carcinoma (OCCC) accounts for approximately 8–10% of epithelial ovarian cancers in the United States. Although it is rare, OCCC usually presents with treatment challenges and the overall pro...

    Authors: Uksha Saini, Brentley Q. Smith, Kalpana Deepa Priya Dorayappan, Ji Young Yoo, G. Larry Maxwell, Balveen Kaur, Ikuo Konishi, David O’Malley, David E. Cohn and Karuppaiyah Selvendiran
    Citation: Journal of Ovarian Research 2022 15:130
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:38

  36. Luteinizing hormone (LH) can stimulate mural granulosa cells to produce Amphiregulin (AREG), which can induce the resumption of meiosis in oocytes. Theca cells are present in the outer layer of follicles, prov...

    Authors: Yang Liu, Yiping Zhong, Xiaoting Shen, Xi Guo, Rihan Wu, Turui Yang and Minghui Chen
    Citation: Journal of Ovarian Research 2022 15:129
    Content type: Research Published on:

  37. Indications of oocyte vitrification increased substantially over the last decades for clinical and ethical reasons. A semi-automated vitrification system was recently developed making each act of vitrification...

    Authors: Julie Barberet, Bastien Ducreux, Céline Bruno, Magali Guilleman, Raymond Simonot, Nicolas Lieury, Adrien Guilloteau, Déborah Bourc’his and Patricia Fauque
    Citation: Journal of Ovarian Research 2022 15:128
    Content type: Research Published on:

  38. Hereditary breast and ovarian cancer (HBOC) syndrome has increased predisposition to breast and/or ovarian cancer, and 24% of families with HBOC were associated with the germline pathogenic variants in BRCA1/2. T...

    Authors: Ying Liu, Jing Zhu, Xiao Wei, Duoxia Yang, Si Li, Xiaoping Qian and Li Li
    Citation: Journal of Ovarian Research 2022 15:127
    Content type: Case Report Published on:

  39. The survival of ovary granulosa cells (GC) is critical in the initiation and progression of polycystic ovary syndrome (PCOS) in females. Here, we found that the PCOS process is accompanied by massive GC pyropt...

    Authors: Zhaowei Cai, Shaojuan He, Rongju Liu, Liling Zhou and Li Zhao
    Citation: Journal of Ovarian Research 2022 15:126
    Content type: Research Published on:

  40. Complex epithelial neoplasms of the ovary (CENO), an uncommon pathological histotype in ovarian cancer, comprises adenosquamous carcinoma and adenocarcinoma with metaplasia. Owing to the rarity of relevant rep...

    Authors: Xiaoxue Li, Yiling Ding, Yang Liu and Mengyuan Yang
    Citation: Journal of Ovarian Research 2022 15:125
    Content type: Research Published on:

  41. Intracytoplasmic sperm injection (ICSI) has become a common method of fertilization in assisted reproduction worldwide. However, there are still gaps in knowledge of the ideal IVF-ICSI workflow including the o...

    Authors: Brandon A. Wyse, Noga Fuchs Weizman, Janice Montbriand, Rima Kharonsky, Ran Antes, Rina Abramov, Svetlana Madjunkova and Clifford L. Librach
    Citation: Journal of Ovarian Research 2022 15:124
    Content type: Research Published on:

  42. Ovarian cancer has the highest mortality rate among gynecological malignant tumors, and it preferentially metastasizes to omental tissue, leading to intestinal obstruction and death. scRNA-seq is a powerful te...

    Authors: Dongni Zhang, Wenping Lu, Shasha Cui, Heting Mei, Xiaoqing Wu and Zhili Zhuo
    Citation: Journal of Ovarian Research 2022 15:123
    Content type: Research Published on:

  43. Primary ovarian insufficiency is characterized by accelerated loss of primordial follicles, which results in ovarian failure and concomitant menopause before age 40. About 1–3% of females in the general popula...

    Authors: Synneva Hagen-Lillevik, Joshua Johnson and Kent Lai
    Citation: Journal of Ovarian Research 2022 15:122
    Content type: Research Published on:

  44. In recent years, silver nanoparticles (AgNPs) have gradually been widely used, especially in the field of anticancer medicine. Ovarian cancer (OC) is the gynaecological malignancy with the highest mortality ra...

    Authors: Man Yin, Xiangyu Xu, Hui Han, Jiahui Dai, Ronghe Sun, Linqing Yang, Junyu Xie and Yunfei Wang
    Citation: Journal of Ovarian Research 2022 15:121
    Content type: Research Published on:

  45. A leading theory for ovarian carcinogenesis proposes that inflammation associated with incessant ovulation is a driver of oncogenesis. Consistent with this theory, nonsteroidal anti-inflammatory drugs (NSAIDs)...

    Authors: Rebecca M. Borneman, Elaine Gavin, Alla Musiyenko, Wito Richter, Kevin J. Lee, David K. Crossman, Joel F. Andrews, Annelise M. Wilhite, Steven McClellan, Ileana Aragon, Antonio B. Ward, Xi Chen, Adam B. Keeton, Kristy Berry, Gary A. Piazza, Jennifer M. Scalici…
    Citation: Journal of Ovarian Research 2022 15:120
    Content type: Research Published on:

  46. Infertility is a global reproductive-health problem, and diminished ovarian reserve (DOR) is one of the common causes of female infertility. Long noncoding RNAs (lncRNAs) are crucial regulators of numerous phy...

    Authors: Li Dong, Xin Xin, Hsun-Ming Chang, Peter C. K. Leung, Chen Yu, Fang Lian and Haicui Wu
    Citation: Journal of Ovarian Research 2022 15:119
    Content type: Research Published on:

  47. Insulin-like peptide 5 (INSL5) is involved in both reproductive and metabolic processes in polycystic ovary syndrome (PCOS). This study aimed to evaluate the relationship between INSL5 and anti-Müllerian hormo...

    Authors: Yijie Chen, Miao Deng, Zhaojing Chen, Shuyang Han, Jun Chen, Hongyan Zhang, Qianwen Wang, Xuejing Jin, Wenhua Liu and Zhifen Zhang
    Citation: Journal of Ovarian Research 2022 15:118
    Content type: Research Published on:

  48. To characterize the gut bacteriome, mycobiome and serum metabolome profiles in polycystic ovary syndrome (PCOS) patients with normal/overweight individuals and evaluate a potential microbiota-related diagnosti...

    Authors: Guoshu Yin, Fu Chen, Guishan Chen, Xiaoping Yang, Qingxia Huang, Lan Chen, Minjie Chen, Weichun Zhang, Miaoqiong Ou, Man Cao, Hong Lin, Man Chen, Hongzhi Xu, Jianlin Ren, Yongsong Chen and Zhangran Chen
    Citation: Journal of Ovarian Research 2022 15:117
    Content type: Research Published on:

  49. The possible impact of ovarian endometriomas (OMAs) on in vitro fertilization (IVF) outcomes remains controversial. Therefore, this study aimed to assess the impact of OMAs on IVF cycle parameters, including o...

    Authors: Cheng Zeng, Ruihui Lu, Xin Li, Yanrong Kuai, Sheng Wang and Qing Xue
    Citation: Journal of Ovarian Research 2022 15:116
    Content type: Research Published on:

  50. Fertility preservation and restoration in cancer patients/survivors is the need of present times when increased numbers of patients get cured of cancer but face infertility as a serious side effect. Resveratro...

    Authors: Sagar Chhabria, Vaishnavi Takle, Nripen Sharma, Prashant Kharkar, Kshama Pansare, Anish Tripathi, Ashish Tripathi and Deepa Bhartiya
    Citation: Journal of Ovarian Research 2022 15:115
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us